Published in Lancet on July 15, 1972
Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg (1988) 2.52
Review of present status of prophylaxis of venous thromboembolism. Proc R Soc Med (1974) 1.37
Prophylaxis of venous thromboembolism: analysis of cost effectiveness. Ann Surg (1980) 1.23
Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen. Br Med J (1977) 1.10
Low-dosage ancrod for prevention of thrombotic complications after surgery for fractured neck of femur. Br Med J (1974) 0.96
Prophylaxis of postoperative leg vine thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial. Br Med J (1975) 0.95
Failure of low dose heparin to prevent pulmonary embolism after hip surgery or above the knee amputation. Ann Surg (1978) 0.90
Optimal electrical stimulus for prevention of deep vein thrombosis. Br Med J (1972) 0.86
Prevention of postoperative deep vein thrombosis by leg bandaging and oxyphenbutazone. Br Med J (1976) 0.86
The risk of thromboembolism in patients undergoing colorectal surgery. Drugs (1996) 0.80
Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers. Br J Clin Pharmacol (1989) 0.80
A comparative analysis of warfarin and low-dose heparin as thromboembolism prophylaxis in total hip replacement patinets. Ann Surg (1975) 0.80
Postsurgical hemorrhage in dogs anticoagulated with ancrod (Arvin). Ann Surg (1973) 0.79
Results of adjusted-dose heparin for thromboembolism prophylaxis in knee replacement compared to those found for its use in hip fracture surgery and elective hip replacement. Iowa Orthop J (2007) 0.78
Prevention of thromboembolism. Bull N Y Acad Med (1973) 0.77
Deep vein thrombosis after thoracotomy. Thorax (1978) 0.77
A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement. Postgrad Med J (1977) 0.76
Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma. Ann Surg (1981) 0.76
Prophylaxis of venous thromboembolism. Proc R Soc Med (1975) 0.76
Editorial: Hypercoagulability--1974. Can Med Assoc J (1974) 0.75
Prevention of pulmonary embolism. Br Med J (1973) 0.75
Treatment of fractures of the neck of the femur. Can Med Assoc J (1977) 0.75
Thromboembolism. Diagnosis and treatment. West J Med (1974) 0.75
Peripheral vascular disease today. Bull N Y Acad Med (1973) 0.75
Progress in peripheral vascular surgery. West J Med (1976) 0.75
Heparin prophylaxis for deep vein thrombosis and pulmonary embolism. West J Med (1976) 0.75
Posttraumatic thromboprophylaxis revisited: an argument against the current methods of DVT and PE prophylaxis after injury. World J Surg (2006) 0.75
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
The detection of venous thrombosis of the legs using 125-I-labelled fibrinogen. Br J Surg (1968) 10.22
Molecular identification and isolation of the Waxy locus in maize. Cell (1983) 9.07
Isolation of the transposable maize controlling elements Ac and Ds. Cell (1983) 5.71
Natural history of postoperative deep-vein thrombosis. Lancet (1969) 5.18
Inactivation of the maize transposable element Activator (Ac) is associated with its DNA modification. EMBO J (1987) 4.91
125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis. Lancet (1970) 4.48
Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta (1972) 4.45
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med (1999) 4.33
Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis. Lancet (1976) 2.77
Deep vein thrombosis of the leg. Is there a "high risk" group? Am J Surg (1970) 2.66
Prospective randomised study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones. Br Med J (Clin Res Ed) (1987) 2.48
Low doses of heparin in prevention of deep-vein thrombosis. Lancet (1971) 2.38
Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med (2001) 2.31
Postoperative deep-vein thrombosis. Effect of intensive prophylaxis. Lancet (1969) 2.09
Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet (1971) 2.08
A physiological study of elastic compression stockings in venous disorders of the leg. Br J Surg (1980) 2.06
Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem (1989) 2.05
Hemorrheologic changes following acute myocardial infarction. Am Heart J (1982) 1.97
The origin of deep vein thrombosis: a venographic study. Br J Radiol (1971) 1.96
Plasma heparin: a unique, practical, submicrogram-sensitive assay. J Lab Clin Med (1973) 1.91
Inguinal herniotomy in children: a five year survey. Br J Surg (1985) 1.82
Treatment of deep vein thrombosis. A trial of heparin, streptokinase, and arvin. Br Med J (1969) 1.82
Late results of treatment of deep vein thrombosis. Br Med J (1969) 1.77
The management of common bile duct calculi by endoscopic sphincterotomy in patients with gallbladders in situ. Br J Surg (1984) 1.76
Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68
The origin of thrombi in the deep veins of the lower limb: a venographic study. Br J Surg (1978) 1.65
Sugar intake, serum insulin and platelet adhesiveness in men with and without peripheral vascular disease. Postgrad Med J (1969) 1.63
Severe subluxation of the cervical spine in rheumatoid arthritis. J Bone Joint Surg Br (1970) 1.63
Cold adaptation and the seasonal distribution of acute myocardial infarction. QJM (1999) 1.62
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food. Science (1978) 1.59
Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene (2006) 1.59
Intravascular coagulation in acute hepatic necrosis. Lancet (1970) 1.56
Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor kappaB and activator protein 1 and the induction of inflammatory cytokines. J Exp Med (1997) 1.55
Activation of activator protein 1 and stress response kinases in epithelial cells colonized by Helicobacter pylori encoding the cag pathogenicity island. J Biol Chem (1999) 1.54
Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br J Haematol (1995) 1.47
A prospective study of ERCP and endoscopic sphincterotomy in the diagnosis and treatment of gallstone acute pancreatitis. A rational and safe approach to management. Arch Surg (1986) 1.46
Study of common bile duct exploration and endoscopic sphincterotomy in a consecutive series of 438 patients. Br J Surg (1987) 1.45
Late-onset homozygous protein C deficiency. Lancet (1991) 1.43
Lipid peroxides and atherosclerosis. BMJ (1989) 1.41
Lung function test findings in patients with chronic fatigue syndrome (CFS) Aust N Z J Med (1996) 1.39
Laparoscopic mobilization and exteriorization for minimally invasive small bowel resection. Br J Surg (1993) 1.39
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet (1994) 1.39
Influence of whole blood on standard curve for heparin measurement--possible heparin binding by red cells. Thromb Haemost (1989) 1.39
The effect of low molecular weight heparin on intimal hyperplasia in vein grafts. Eur J Vasc Surg (1994) 1.39
Fibrinolytic activity and postoperative deep-vein thrombosis. Lancet (1974) 1.39
An objective study of alternative methods of heparin administration. Thromb Res (1980) 1.38
Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet (1976) 1.38
Review of present status of prophylaxis of venous thromboembolism. Proc R Soc Med (1974) 1.37
Myocardial infarction and deep-vein thrombosis. Br Med J (1971) 1.33
Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol (1977) 1.30
Choledochoduodenostomy, transduodenal sphincteroplasty and sphincterotomy for calculi of the common bile duct. Surg Gynecol Obstet (1987) 1.29
Molecular analysis of the maize wx-B3 allele indicates that precise excision of the transposable Ac element is rare. Genetics (1992) 1.29
Plasma exchange and platelet function in Raynaud's phenomenon. Thromb Res (1981) 1.28
Haemorrheological response to plasma exchange in Raynaud's syndrome. Br Med J (1979) 1.28
Endotoxaemia and renal failure in cirrhosis and obstructive jaundice. Br Med J (1976) 1.25
The changing pattern of venous thromboembolic disease. Haemostasis (1997) 1.23
Laboratory control of heparin therapy. J Clin Pathol (1971) 1.20
Graduated, static, external compression of the lower limb: a physiological assessment. Br J Surg (1980) 1.18
Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br (1989) 1.18
Deep-vein thrombosis in patients with fractures of the femoral neck. Br J Surg (1972) 1.18
Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroenterol Suppl (1973) 1.18
beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol (1983) 1.16
Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. Br Med J (Clin Res Ed) (1982) 1.16
Detection of gall stones after acute pancreatitis. Gut (1985) 1.15
Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg (1981) 1.15
Rabbit plasma inhibitor of the activated species of blood coagulation factor X. Purification and some properties. J Biol Chem (1971) 1.15
Theory and practice of minidose heparin in surgical patients. A status report. Circulation (1973) 1.14
Liver transplantation in man--IV, Haemorrhage and thrombosis. Br Med J (1969) 1.14
Nucleotide sequence of the maize Mutator element, Mu8. Nucleic Acids Res (1990) 1.13
Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor. Biochim Biophys Acta (1970) 1.12
Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selection. Hum Mutat (1995) 1.12
Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11
Detection of deep vein thrombosis: survey and current status. Prog Cardiovasc Dis (1975) 1.11
Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1995) 1.11
The problems of thrombosis in the deep veins of the leg. Ann R Coll Surg Engl (1969) 1.11
Disorderd hemostasis in liver damage from paracetamol overdose. Gastroenterology (1973) 1.10
Femoral vein thrombosis and total hip replacement. Br Med J (1977) 1.10
Treatment of deep-vein thrombosis with streptokinase. Br J Surg (1969) 1.10
Fibrinogen metabolism in acute hepatitis and active chronic hepatitis. Br J Haematol (1975) 1.10
The I 125 -labeled fibrinogen test and phlebography in the diagnosis of deep vein thrombosis. Milbank Mem Fund Q (1972) 1.09
Plasma heparin levels after administration of calcium and sodium salts of heparin. Thromb Res (1976) 1.09
Deep vein thrombosis. Detection and prevention. Circulation (1975) 1.08
The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg (1978) 1.08
The cephalic vein as a peripheral vascular graft. Surg Gynecol Obstet (1969) 1.07
World Health Organization initiative to estimate the global burden of foodborne diseases. Rev Sci Tech (2013) 1.07
Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol (2000) 1.07